Detail Information of Post-Translational Modifications

General Information of Drug Transporter (DT)
DT ID	DTD0113 Transporter Info
Gene Name	SLC16A9
Transporter Name	Monocarboxylate transporter 9
Gene ID	220963
UniProt ID	Q7RTY1

Post-Translational Modification of This DT
Overview of SLC16A9 Modification Sites with Functional and Structural Information
Sequence	M E L K K S P D G G W G W V I V F V S F L T Q F L C Y G S P L A V G V L Y I E W L D A F G E G K G K T A W V G S L A S G V G L L A S P V C S L C V S S F G A R P V T I F S G F M V A G G L M L S S F A P N I Y F L F F S Y G I V V G L G C G L L Y T A T V T I T C Q Y F D D R R G L A L G L I S T G S S V G L F I Y A A L Q R M L V E F Y G L D G C L L I V G A L A L N I L A C G S L M R P L Q S S D C P L P K K I A P E D L P D K Y S I Y N E K G K N L E E N I N I L D K S Y S S E E K C R I T L A N G D W K Q D S L L H K N P T V T H T K E P E T Y K K K V A E Q T Y F C K Q L A K R K W Q L Y K N Y C G E T V A L F K N K V F S A L F I A I L L F D I G G F P P S L L M E D V A R S S N V K E E E F I M P L I S I I G I M T A V G K L L L G I L A D F K W I N T L Y L Y V A T L I I M G L A L C A I P F A K S Y V T L A L L S G I L G F L T G N W S I F P Y V T T K T V G I E K L A H A Y G I L M F F A G L G N S L G P P I V G W F Y D W T Q T Y D I A F Y F S G F C V L L G G F I L L L A A L P S W D T C N K Q L P K P A P T T F L Y K V A S N V
PTM type	X-Phosphorylation X-Ubiquitination X: Amino Acid

Phosphorylation
Serine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC16A9			[1] , [2]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	212
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC16A9 Serine 212 has the potential to affect its expression or activity.
Threonine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC16A9			[3]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	145
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC16A9 Threonine 145 has the potential to affect its expression or activity.
Tyrosine	4 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC16A9			[3]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	154
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC16A9 Tyrosine 154 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC16A9			[1] , [2]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	211
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC16A9 Tyrosine 211 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC16A9			[1] , [2]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	214
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC16A9 Tyrosine 214 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence SLC16A9			[4]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	277
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC16A9 Tyrosine 277 has the potential to affect its expression or activity.
Ubiquitination
Cystine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC16A9			[5]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	184
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC16A9 Cystine 184 has the potential to affect its expression or activity.
Glutamine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC16A9			[6]
Role of PTM	Potential impacts
Modified Residue	Glutamine	Modified Location	130
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC16A9 Glutamine 130 has the potential to affect its expression or activity.
Isoleucine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC16A9			[5] , [6]
Role of PTM	Potential impacts
Modified Residue	Isoleucine	Modified Location	143
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC16A9 Isoleucine 143 has the potential to affect its expression or activity.
Leucine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC16A9			[6]
Role of PTM	Potential impacts
Modified Residue	Leucine	Modified Location	161
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC16A9 Leucine 161 has the potential to affect its expression or activity.
Lysine	6 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC16A9			[6]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	217
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC16A9 Lysine 217 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC16A9			[6] , [7]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	219
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC16A9 Lysine 219 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC16A9			[5] , [6]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	230
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC16A9 Lysine 230 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence SLC16A9			[6] , [8]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	248
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC16A9 Lysine 248 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence SLC16A9			[5]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	271
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC16A9 Lysine 271 has the potential to affect its expression or activity.
PTM Phenomenon 6	Have the potential to influence SLC16A9			[7] , [8]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	504
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC16A9 Lysine 504 has the potential to affect its expression or activity.
Phenylalanine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC16A9			[6] , [7]
Role of PTM	Potential impacts
Modified Residue	Phenylalanine	Modified Location	132
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC16A9 Phenylalanine 132 has the potential to affect its expression or activity.
Tyrosine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC16A9			[7] , [9]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	417
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC16A9 Tyrosine 417 has the potential to affect its expression or activity.
Unclear Residue	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC16A9			[9]
Role of PTM	Potential impacts
Modified Location	546
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC16A9 546 has the potential to affect its expression or activity.

References
1	Identification of missing proteins in the neXtProt database and unregistered phosphopeptides in the PhosphoSitePlus database as part of the Chromosome-centric Human Proteome Project. J Proteome Res. 2013 Jun 7;12(6):2414-21.
2	Functional Proteomics Identifies Acinus L as a Direct Insulin- and Amino Acid-Dependent Mammalian Target of Rapamycin Complex 1 (mTORC1) Substrate. Mol Cell Proteomics. 2015 Aug;14(8):2042-55.
3	Identification of Missing Proteins in the Phosphoproteome of Kidney Cancer. J Proteome Res. 2017 Dec 1;16(12):4364-4373.
4	Neuroblastoma tyrosine kinase signaling networks involve FYN and LYN in endosomes and lipid rafts. PLoS Comput Biol. 2015 Apr 17;11(4):e1004130.
5	UbiSite approach for comprehensive mapping of lysine and N-terminal ubiquitination sites. Nat Struct Mol Biol. 2018 Jul;25(7):631-640.
6	Systematic functional prioritization of protein posttranslational modifications. Cell. 2012 Jul 20;150(2):413-25.
7	Global Landscape and Dynamics of Parkin and USP30-Dependent Ubiquitylomes in iNeurons during Mitophagic Signaling. Mol Cell. 2020 Mar 5;77(5):1124-1142.e10.
8	Systematic and quantitative assessment of the ubiquitin-modified proteome. Mol Cell. 2011 Oct 21;44(2):325-40.
9	A proteome-wide, quantitative survey of in vivo ubiquitylation sites reveals widespread regulatory roles. Mol Cell Proteomics. 2011 Oct;10(10):M111.013284.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.

Detail Information of Post-Translational Modifications

Visitor Map

Correspondence